pubmed-article:7966657 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7966657 | lifeskim:mentions | umls-concept:C0241961 | lld:lifeskim |
pubmed-article:7966657 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:7966657 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:7966657 | lifeskim:mentions | umls-concept:C0868928 | lld:lifeskim |
pubmed-article:7966657 | pubmed:issue | 6 Pt 1 | lld:pubmed |
pubmed-article:7966657 | pubmed:dateCreated | 1994-12-12 | lld:pubmed |
pubmed-article:7966657 | pubmed:abstractText | Angiomyolipomas were found in 42 kidneys in 23 female and 8 male patients at our medical center. Angiomyolipoma was diagnosed by computerized tomography (CT) alone in 55% of the cases, and by a combination of ultrasound and CT in 36%. Nine of 11 patients with bilateral angiomyolipoma had associated tuberous sclerosis. Treatment consisted of observation in 22 patients, selective arterial embolization in 6, partial nephrectomy in 6 and nephrectomy in 8. A total of 17 patients who were observed had tumors smaller than 4 cm. and 4 h had angiomyolipoma of 4 to 10 cm. With a mean followup of 3.8 years, no observation patient had subsequent renal hemorrhage and only 1 (tumor larger than 10 cm.) had radiographic progression. Despite progression, the latter patient remained asymptomatic for 18 years. Selective arterial embolization (3 tumors 4 to 10 cm. and 3 larger than 10 cm.) resulted in preservation of renal function at a mean of 1 year. All patients treated with partial nephrectomy (6 tumors 4 to 10 cm.) maintained stable renal function without recurrence during a mean 4.7-year followup. Similarly, all individuals who underwent nephrectomy (4 tumors smaller than 4 cm., 3 tumors 4 to 10 cm. and 1 tumor larger than 10 cm.) have stable renal function. We recommend renal conservation for patients with renal angiomyolipoma using a strategy of observation for small asymptomatic tumors, partial nephrectomy for moderate size tumors and selective arterial embolization of large tumors not amenable to partial nephrectomy. | lld:pubmed |
pubmed-article:7966657 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7966657 | pubmed:language | eng | lld:pubmed |
pubmed-article:7966657 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7966657 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:7966657 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7966657 | pubmed:month | Dec | lld:pubmed |
pubmed-article:7966657 | pubmed:issn | 0022-5347 | lld:pubmed |
pubmed-article:7966657 | pubmed:author | pubmed-author:ChoK JKJ | lld:pubmed |
pubmed-article:7966657 | pubmed:author | pubmed-author:GrossmanH BHB | lld:pubmed |
pubmed-article:7966657 | pubmed:author | pubmed-author:KennellyM JMJ | lld:pubmed |
pubmed-article:7966657 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7966657 | pubmed:volume | 152 | lld:pubmed |
pubmed-article:7966657 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7966657 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7966657 | pubmed:pagination | 1988-91 | lld:pubmed |
pubmed-article:7966657 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:meshHeading | pubmed-meshheading:7966657-... | lld:pubmed |
pubmed-article:7966657 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7966657 | pubmed:articleTitle | Outcome analysis of 42 cases of renal angiomyolipoma. | lld:pubmed |
pubmed-article:7966657 | pubmed:affiliation | Department of Surgery, University of Michigan Medical Center, Ann Arbor. | lld:pubmed |
pubmed-article:7966657 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7966657 | pubmed:publicationType | Clinical Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966657 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966657 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966657 | lld:pubmed |